Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05087095 · ClinicalTrials.gov registry record · NA

Managing Distress in Malignant Brain Cancer

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05087095 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05087095, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

To identify potential adaptations of the managing cancer and living meaningfully (CALM) intervention that will be required for service members, Veterans, their beneficiaries, and civilian cancer metastasis to the brain (bMET) populations.

Interventions

  • BEHAVIORAL CALM Intervention

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-03-23
Est. Completion 2023-11-01
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05087095

The ClinicalTrials.gov registry entry for NCT05087095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CALM Intervention is the first listed.

NCT05087095 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05087095 about?

NCT05087095 is a clinical study titled "Managing Distress in Malignant Brain Cancer". To identify potential adaptations of the managing cancer and living meaningfully (CALM) intervention that will be required for service members, Veterans, their beneficiaries, and civilian cancer metastasis to the brain (bMET) populations.

What is the current status of trial NCT05087095?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-03-23. Estimated completion is 2023-11-01.

What interventions are being tested in trial NCT05087095?

The interventions under investigation include: CALM Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05087095?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.